Literature DB >> 6694707

Ventriculostomy-related infections. A prospective epidemiologic study.

C G Mayhall, N H Archer, V A Lamb, A C Spadora, J W Baggett, J D Ward, R K Narayan.   

Abstract

We concluded a prospective epidemiologic study of ventriculostomy-related infections (ventriculitis or meningitis) in 172 consecutive neurosurgical patients over a two-year period to determine the incidence, risk factors, and clinical characteristics of the infections. Ventriculitis or meningitis developed in 19 of 172 patients (11 per cent) undergoing a total of 213 ventriculostomies. When data from all these cases plus five cases of nonventriculostomy-related infection were combined, cerebrospinal-fluid pleocytosis was more significantly associated with the diagnosis of ventriculitis or meningitis (P less than 0.0001) than were fever and leukocytosis (P = 0.07). Risk factors for ventriculostomy-related infections included intracerebral hemorrhage with intraventricular hemorrhage (P = 0.027), neurosurgical operations (P = 0.016), intracranial pressure of 20 mm Hg or more (P = 0.019), ventricular catheterization for more than five days (P = 0.017), and irrigation of the system (P = 0.021). Previous ventriculostomy did not increase the risk of infection with subsequent procedures. We conclude that ventriculostomy-related infections may be prevented by maintenance of a closed drainage system and by early removal of the ventricular catheter. If monitoring is required for more than five days, the catheter should be removed and inserted at a different site.

Entities:  

Mesh:

Year:  1984        PMID: 6694707     DOI: 10.1056/NEJM198403013100903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  97 in total

1.  Complications of brain tissue pressure monitoring with a fiberoptic device.

Authors:  A Bekar; S Gören; E Korfali; K Aksoy; S Boyaci
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 2.  Neurocritical care and traumatic brain injury.

Authors:  R C Tasker
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

3.  Evaluation of minimally invasive percutaneous CT-controlled ventriculostomy in patients with severe head trauma.

Authors:  M Krötz; U Linsenmaier; K G Kanz; K J Pfeifer; W Mutschler; M Reiser
Journal:  Eur Radiol       Date:  2003-11-06       Impact factor: 5.315

Review 4.  Analysis of intracranial pressure.

Authors:  D J Doyle; P W Mark
Journal:  J Clin Monit       Date:  1992-01

5.  The risk factors of external ventricular drainage-related infection at hospital kuala lumpur: an observational study.

Authors:  Mohamad Azhari Omar; Mohd Saffari Mohd Haspani
Journal:  Malays J Med Sci       Date:  2010-07

Review 6.  Strategies to decrease the risk of ventricular catheter infections: a review of the evidence.

Authors:  Maya A Babu; Robin Patel; W Richard Marsh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

Review 7.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

Review 8.  Infections associated with indwelling devices: infections related to extravascular devices.

Authors:  G M Dickinson; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

9.  Risk factors associated with infections and need for permanent cerebrospinal fluid diversion in pediatric intensive care patients with externalized ventricular drains.

Authors:  Alexis A Topjian; Amber Stuart; Alyssa A Pabalan; Ashleigh Clair; Todd J Kilbaugh; Nicholas S Abend; Robert A Berg; Gregory G Heuer; Phillip B Storm; Jimmy W Huh; Stuart H Friess
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

Review 10.  [Aneurysmal subarachnoid hemorrhage. Significance and complications].

Authors:  A S Sarrafzadeh; U Kaisers; W Boemke
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.